Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger

Calendrier Economique
Signaux de trading
Terminal Web

Tapez / pour rechercher : @user, $symbol Recherche

English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe

MGX

#3462

Metagenomi Therapeutics, Inc. Common Stock

1.5200

-1.83%

Secteur:

Base:

Devise de Profit:

Range quotidien

1.5200

1.5200

Range Annuel

1.4100

1.5850

Changement quotidien

-1.83%

Changement Mensuel

+5.56%

Evolution sur 6 mois

+5.56%

Changement Annuel

+5.56%

Clôture Précédente

1.5484

Open

1.5200

Bid

Ask

Low

1.5200

High

1.5200

Volume

4

Marchés
Actions des Marchés US
Soins de Santé
MGX

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Income statement Balance sheet Cash flow

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 11.51 M9.61 M4.13 M8.51 M8.66 M 30.91 M Gross profit 11.51 M9.61 M4.13 M8.51 M8.66 M 30.91 M Operating expenses 33.9 M30.24 M31.95 M29.5 M31.5 M 123.18 M Selling/general/admin expenses 7.64 M7.07 M6.8 M6.99 M6.21 M 27.09 M Research & development 26.26 M23.16 M25.14 M22.51 M25.28 M 96.1 M Operating income 22.38 M20.62 M27.82 M20.99 M22.84 M 92.27 M Non-Operating Income, Total 1.5 M-3.98 M2.88 M1.12 M2.21 M 2.23 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 1.45 M-4.03 M2.87 M1.05 M2.21 M 2.1 M Unusual income/expense 57 K49 K8 00070 K2 000 129 K Pretax income 20.88 M24.61 M24.94 M19.86 M20.63 M 90.04 M Equity in earnings ————— — Taxes 2.11 M1.21 M98 K44 K234 K 1.58 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 18.77 M23.4 M25.04 M19.91 M20.39 M 88.74 M Discontinued operations ————— — Net income 18.77 M23.4 M25.04 M19.91 M20.39 M 88.74 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 18.77 M23.4 M25.04 M19.91 M20.39 M 88.74 M Basic earnings per share (Basic EPS) -0.51-0.37-0.68-0.54-0.55 -2.14 Diluted earnings per share (Diluted EPS) -0.51-0.37-0.68-0.54-0.55 -2.14 Average basic shares outstanding 36.77 M33.03 M37.02 M37.16 M37.35 M 144.55 M Diluted shares outstanding 36.77 M33.03 M37.02 M37.16 M37.35 M 144.55 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) -262 K112 K351 K517 K619 K 1.6 M

Nouvelles

avant-hier, 22:30

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates

Marchés

Actions
Devises
Crypto-monnaies
Métaux
Matières premières

Graphique & Idées

Idées de Trading
Idées de Formations
Graphiques

MQL5 Community

Marché
Signaux
Forum
Articles
CodeBase

Nouvelles

Actions
Devises
Crypto-monnaies
Métaux
Matières premières

Courtiers

Tous les Courtiers
Forex
Actions
Métaux

Economic Calendar

Clause de Non-Responsabilité et Divulgation des Risques Conditions d'Utilisation Contacts et Demandes Légal

Copyright 2000-2026, MetaQuotes Ltd